NZ335545A - Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56 - Google Patents

Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56

Info

Publication number
NZ335545A
NZ335545A NZ335545A NZ33554597A NZ335545A NZ 335545 A NZ335545 A NZ 335545A NZ 335545 A NZ335545 A NZ 335545A NZ 33554597 A NZ33554597 A NZ 33554597A NZ 335545 A NZ335545 A NZ 335545A
Authority
NZ
New Zealand
Prior art keywords
cmrf
binds
dendritic cell
specific antibodies
activated antigen
Prior art date
Application number
NZ335545A
Inventor
Derek Nigel John Hart
Original Assignee
Order Sisters Of Mercy Queensl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Order Sisters Of Mercy Queensl filed Critical Order Sisters Of Mercy Queensl
Priority to NZ335545A priority Critical patent/NZ335545A/en
Priority claimed from PCT/NZ1997/000134 external-priority patent/WO1998015579A1/en
Publication of NZ335545A publication Critical patent/NZ335545A/en

Links

Abstract

A monoclonal antibody or binding fragments thereof which specifically bind to dendritic cells activation antigen CMRF-56. Disclosed is a hybridoma cell line CMRF-56 which secretes mAb CMRF-56. The secreted mAb CMRF-56 binds specifically to an epitope on activated human dendritic cell but does not bind to activation antigens CMRF-44 and CD83. The process provides a method for identifying and purifying dendritic cells from blood using such antibodies.
NZ335545A 1996-10-09 1997-10-09 Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56 NZ335545A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ335545A NZ335545A (en) 1996-10-09 1997-10-09 Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ29953796 1996-10-09
PCT/NZ1997/000134 WO1998015579A1 (en) 1996-10-09 1997-10-09 Dendritic cell-specific antibodies
NZ335545A NZ335545A (en) 1996-10-09 1997-10-09 Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56

Publications (1)

Publication Number Publication Date
NZ335545A true NZ335545A (en) 2001-01-26

Family

ID=26651677

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ335545A NZ335545A (en) 1996-10-09 1997-10-09 Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56

Country Status (1)

Country Link
NZ (1) NZ335545A (en)

Similar Documents

Publication Publication Date Title
DE69503903D1 (en) POSITIVE AND POSITIVE / NEGATIVE CELL SELECTION BROKEN BY PEPTIO RELEASE
IL148113A0 (en) Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
ES2106195T3 (en) IGG AGLYCOSILATED ANTIBODY ANTI CD3.
AU4485696A (en) Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen
HK1115607A1 (en) Human cytokine receptor
GB9317423D0 (en) Monoclonal antibodies
MD1374G2 (en) Monoclonal immunostimulatin antibodies, method of obtaining thereof, cell lines, method of disease treatment and pharmaceutical composition
EP2186884A3 (en) HCV-anti-core monoclonal antibody
IL116617A0 (en) Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
EP0499176A3 (en) Monoclonal antibodies against human pancreatic islet cells
IL154000A (en) Method employing antibodies for diagnosing rheumatoid arthritis
EP0352722A3 (en) Adenocarcinoma antigen binding methods and reagents
IL123736A0 (en) Tryptase polyclonal antibody and purification method for use in human immunoassay
CA2036814A1 (en) Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof
AU2003283240A1 (en) Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
NZ335545A (en) Monoclonal dendritic cell (DC)-specific antibodies that binds to DC activated antigen CMRF-56
EP0323802A3 (en) Monoclonal antibodies against, and cell surface antigen of, lung carcinoma
ATE213838T1 (en) METHOD AND REAGENTS FOR THE IMMUNOLOGICAL DETECTION OF CORTISOL IN URINE
AU5039290A (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
EP0696597A3 (en) Monoclonal antibodies for selective immunological determination of high molecular weight intact laminin forms in body fluids
WO1987007302A3 (en) MONOCLONAL ANTIBODIES TO HUMAN LYMPHOCYTE IgE RECEPTORS, HYBRIDOMAS PRODUCING SUCH ANTIBODIES, AND KITS FOR USING SUCH ANTIBODIES
EP0155172A3 (en) Anti-human lung cancer monoclonal antibodies
ATE143146T1 (en) METHOD AND REAGENT FOR DETERMINING THE FOLLICLE-STIMULATING HORMON AND MONOCLONAL ANTIBODIES SUITABLE FOR THIS
ES2009365A6 (en) Method for treating gram negative bacterial infections in humans
CA2365639A1 (en) Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired